Assessment of the introduction of a blood management program in orthopaedic surgery;Valoración de la implementación de programa de ahorro de sangre en cirugía ortopédica

Revista Espanola de Anestesiologia y Reanimacion

Volumn 62, Issue 8, 2015, Pages 443-449

  Albinarrate, A ^a   Lopez Picado A ^a   Oiartzabal, I ^a   Lopez Ariznabarreta C ^a   Molano, J ^a   Barrachina, B ^a  

^a HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Blood; Patient blood management; Tranexamic acid; Transfusion

Indexed keywords

BIOLOGICAL MARKER; FERRIC ION; FERRIC OXIDE, SACCHARATED; HEMOGLOBIN; SACCHARIC ACID; TRANEXAMIC ACID;

ADVERSE EFFECTS; AGED; ANEMIA; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD SALVAGE; BLOOD TRANSFUSION; FEMALE; HIP REPLACEMENT; HUMAN; KNEE REPLACEMENT; LENGTH OF STAY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; ORGANIZATION AND MANAGEMENT; ORTHOPEDICS; POSTOPERATIVE HEMORRHAGE; PROGRAM EVALUATION; RETROSPECTIVE STUDY; SPAIN; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL; UTILIZATION;

AGED; ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOMARKERS; BLOOD BANKS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; FERRIC COMPOUNDS; GLUCARIC ACID; HEMOGLOBINS; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; ORTHOPEDICS; POSTOPERATIVE HEMORRHAGE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SPAIN; TRANEXAMIC ACID;

EID: 84941286331     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2014.09.004     Document Type: Article

References (10)

1. Goodnough L.T., Maniatis A., Earnshaw P., Benoni G., Beris P., Bisbe E., et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011, 106:13-22.
2. Rohde J.M., Dimcheff D.E., Blumberg N., Saint S., Langa K.M., Kuhn L., et al. Health care-associated infection after red blood cell transfusion: A systematic review and meta-analysis. JAMA 2014, 311:1317-1326.
3. Spahn D.R., Goodnough L.T. Alternatives to blood transfusión. Lancet 2012, 381:1855-1865.
4. Bisbe E., Castillo J., Nomen N., Mestre C., Gonzalez R., Comps O. Eritropoyetina preoperatoria como estrategia de ahorro de sangre en cirugía ortopédica mayor en pacientes de edad avanzada. Med Clin (Barc) 2004, 123:413-415.
5. Spahn D.R. Anemia and patient blood management in hip and knee surgery. A systematic review of the literature. Anesthesiology 2010, 113:482-495.
6. Leal-Noval S.R., Muñoz M., Asuero M., Contreras E., Garcia-Erce J.A., Llau J.V., et al. Documento Sevilla de consenso sobre alternativas a la transfusión de sangre alogénica. Actualización del documento Sevilla. Rev Esp Anestesiol Reanim 2013, 60:263. e1-25.
7. Leal R., Alberca I., Asuero M.S., Bóveda J.L., Carpio N., Contreras E., et al. Documento «Sevilla» de consenso sobre alternativas a la transfusión de sangre alogénica. Med Clin (Barc) 2006, 127 Supl 1:3-20.
8. Kotzé A., Carter L.A., Scally A.J. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: A quality improvement cycle. Br J Anaesth 2012, 108:943-952.
9. Alshryda S., Sarda P., Sukeik M., Nargol A., Blenkinsopp J., Mason J.M. Tranexamic acid in total knee replacement Instructional review: Knee. A systematic review and meta-analysis. J Bone Joint Surg Br 2011, 93:1577-1585.
10. Sukeik M., Alshryda S., Haddad F.S., Mason J.M. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg 2011, 93:39-46.